ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

Moves Forward With Approval From BSA

November 22, 2013

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

In Brief: Henry Kaplan Dies Of Lung Cancer At 65; LED Development Of Hodgkin’s Disease Treatment

February 10, 1984

House Committee Proposes $750 Mil. Increase For NIH, supports Bypass

May 4, 1990

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997